Autoimmune: Page 5

New biosensor aids early diagnosis of breast cancer
By LabPulse.com staff writers
In a study published in ACS Sensors, a research team led by Dr. Ramón Martínez Máñez from Valencia Polytechnic University noted that mammography is the gold standard for breast cancer detection, but radiation and lower sensitivity and specificity in young women with dense breast tissue are drawbacks to the imaging technology.
May 20, 2021
2021 05 21 20 55 6118 Breast Cancer 3 D 400
Labcorp to buy intellectual property from Myriad Genetics
By LabPulse.com staff writers
Vectra is a blood-based test that evaluates 12 biomarkers for rheumatoid arthritis activity. More than 1 million Vectra tests have been performed since Myriad launched it in 2010, according to Labcorp.
May 2, 2021
2019 04 26 21 48 5250 Money Hundred Bills 400
BrainChip, NaNose laud progress in breath sample COVID-19 test
By LabPulse.com staff writers
The test incorporates NaNose Medical's sensor array to collect data and BrainChip's Akida artificial intelligence chip to perform the diagnosis, according to the two firms. NaNose's sensory array is based on technology developed at Technion Israel Institute of Technology in Haifa, and has similar sensitivity to minute quantities of volatile organic compounds (VOCs) as a dog's nose.
February 24, 2021
2021 02 25 23 48 3444 Covid Virus Dna Molecule 400
Hologic wraps up Biotheranostics acquisition
By LabPulse.com staff writers
Hologic had unveiled plans to acquire Biotheranostics for $230 million in January. Through the deal, Hologic gains two laboratory-developed tests -- the Breast Cancer Index, which predicts effects of endocrine therapy in breast cancer patients and CancerType ID, which aids in the molecular characterization of uncertain and unknown cancers.
February 21, 2021
2020 01 02 21 24 9838 Hologic Rsna 2019 400
Man's best friend helps train neural network for prostate cancer
By Joseph Constance
Researchers with Medical Detection Dogs of the U.K. studied the olfactory ability of dogs to detect aggressive prostate cancer from urine samples and used it to train an artificial neural network (ANN) to better detect cancer in diagnostics. They found that the cancer-sniffing ability of the canines was just one of several factors that could be used to optimize their neural network.
February 17, 2021
2021 02 17 17 07 0976 Dog Paw Hand 400
Patients approve of medical screening at dental offices
By Emily Hayes
In the survey of 573 people, 89% were willing to have their dentist take their blood pressure and 82.9% were willing to undergo lab investigations for medical conditions, researchers from Saudi Arabia reported in a paper published February 2 in the open-access journal Dovepress.
February 4, 2021
2018 10 11 20 26 7990 Patient Woman Doctor 400
Qiagen debuts solution for SARS-CoV-2 T-cell research
By LabPulse.com staff writers
QuantiFeron SARS-CoV-2 ROU is a modular system based on the platform Qiagen developed for its QuantiFeron-TB Gold Plus test for latent tuberculosis.
December 6, 2020
2019 11 19 19 30 0103 T Cell 400
Vaccines won't eliminate the need for COVID-19 testing
By Bruce Carlson
It may be natural to suspect that if a vaccine is available, there will be fewer cases thus less reason to test. But this isn't normally the interplay between vaccines and diseases.
November 23, 2020
2020 11 19 03 54 0444 Senior Swab Test 400
BioMerieux debuts clinical informatics software
By LabPulse.com staff writers
The Clarion software-as-a-service tool aids antimicrobial stewardship programs at labs and hospitals. The software provides critical infectious disease data and increased visibility for the value of diagnostics, the company noted.
November 22, 2020
2019 08 20 21 56 4986 Biomerieux Aacc 2019 400
Who should get the 1st COVID-19 vaccines?
By Leah Sherwood
Current strategic prioritization plans emphasize the importance of vaccinating healthcare workers, since doing so preserves the healthcare system itself. Another priority is to directly protect the elderly and people with comorbidities, who are at the highest risk of death or hospitalization from COVID-19.
October 25, 2020
2020 10 24 00 06 5467 Viral Like Particles Vaccine 400
Inova gets CE Mark for autoimmune assays
By LabPulse.com staff writers
Inova's PMAT technology processes multiple analytes simultaneously from a patient sample, according to the company. The platform features a 150-sample rack capacity and a 6.5-hour consumable walkaway time. It also provides up to 720 results per hour using a 12-analyte test cartridge, Inova said.
August 25, 2020
2020 08 26 22 23 0503 2020 08 26 Inova 400
Fujifilm Medical to add IVD to portfolio
By LabPulse.com staff writers
Fujifilm Wako Diagnostics has developed biomarkers that assess the risk of hepatocellular carcinoma in patients with chronic liver disease, as well as IVD reagents for disorders of lipid metabolism, lupus, rheumatoid arthritis, coronary heart disease, and diabetes, according to Fujifilm Medical Systems.
August 16, 2020
2020 08 17 23 11 0044 Fujifilm Rsna 2019 400
Previous Page
Page 5 of 9
Next Page